Covance Clinical Trials
Sponsors / Covance
ClinicalTrials.gov lists 61 trials for which Covance is named as lead sponsor. Of these, 1 are recruiting, 0 are active without new recruitment, and 45 have completed. The registry records 10 terminated or withdrawn trials for Covance. The most common reasons cited for termination include slow or insufficient recruitment, safety concerns. Planned participant enrollment across these trials sums to 6,177. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
61
Total Trials
1
Recruiting
0
Other Active
45
Completed
10
Terminated / Withdrawn
6,177
Total Enrollment
Termination reasons: Other50% · Recruitment30% · Safety10% · Business10%
Recent Terminations
- Clear Cell Renal Cell Carcinoma"sponsor decision"
- Filariasis, Lymphatic"Safety issues"
- Atopic Dermatitis"Difficulty in enrollment and COVID-19 pandemic."
- Polycystic Ovary Syndrome (PCOS)"The risk/benefit profile no longer indicated continued development."
- Healthy
- Healthy"Poor recruitment of fast and slow acetylators"
- Healthy"Difficulty finding the required subject population"
- Colon Polyps
- Flexible Bronchoscopy"Patient enrollment was stopped prior to completion of the study in order to re-evaluate the dosing regimen."
- Arthroscopy
Active Trials (0 total)
- Coronary Artery Disease PHASE1/PHASE2NCT04604782